{"id":"https://openalex.org/W7224627504","doi":"https://doi.org/10.1021/acs.jmedchem.6c02236","title":"Preclinical Characterization of [68Ga]Ga/[177Lu]Lu-PSNT-AB: A Dual-Targeted Agent against PSMA and NTSR1 for Prostate Cancer Theranostics","display_name":"Preclinical Characterization of [68Ga]Ga/[177Lu]Lu-PSNT-AB: A Dual-Targeted Agent against PSMA and NTSR1 for Prostate Cancer Theranostics","publication_year":2026,"publication_date":"2026-10-29","ids":{"openalex":"https://openalex.org/W7224627504","doi":"https://doi.org/10.1021/acs.jmedchem.6c02236"},"language":"en","primary_location":{"id":"doi:10.1021/acs.jmedchem.6c02236","doi":"https://doi.org/10.1021/acs.jmedchem.6c02236","is_oa":false,"landing_page_url":"https://doi.org/10.1021/acs.jmedchem.6c02236","pdf_url":null,"source":{"id":"https://openalex.org/S162030435","display_name":"Journal of Medicinal Chemistry","issn_l":"0022-2623","issn":["0022-2623","1520-4804"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","jufo-3","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320006","host_organization_name":"American Chemical Society","host_organization_lineage":["https://openalex.org/P4310320006"],"host_organization_lineage_names":["American Chemical Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Medicinal Chemistry","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5160096918","display_name":"Quan Xie","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I83519826","display_name":"Nanjing Medical University","ror":"https://ror.org/059gcgy73","country_code":"CN","type":"education","lineage":["https://openalex.org/I83519826"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Quan Xie","raw_affiliation_strings":["Jiangsu Institute of Nuclear Medicine , , ,","Nanjing Medical University , , ,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Jiangsu Institute of Nuclear Medicine , , ,","institution_ids":[]},{"raw_affiliation_string":"Nanjing Medical University , , ,","institution_ids":["https://openalex.org/I83519826"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5160075613","display_name":"Ying Peng","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ying Peng","raw_affiliation_strings":["Jiangsu Institute of Nuclear Medicine , , ,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Jiangsu Institute of Nuclear Medicine , , ,","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008989263","display_name":"Qingzhu Liu","orcid":"https://orcid.org/0000-0001-7692-6211","observed_orcids":["https://orcid.org/0000-0001-7692-6211","https://orcid.org/0000-0002-9695-2246"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Qingzhu Liu","raw_affiliation_strings":["Jiangsu Institute of Nuclear Medicine , , ,"],"raw_orcid":"https://orcid.org/0000-0001-7692-6211","affiliations":[{"raw_affiliation_string":"Jiangsu Institute of Nuclear Medicine , , ,","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5160077039","display_name":"Jiawen Qin","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I83519826","display_name":"Nanjing Medical University","ror":"https://ror.org/059gcgy73","country_code":"CN","type":"education","lineage":["https://openalex.org/I83519826"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Jiawen Qin","raw_affiliation_strings":["Jiangsu Institute of Nuclear Medicine , , ,","Nanjing Medical University , , ,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Jiangsu Institute of Nuclear Medicine , , ,","institution_ids":[]},{"raw_affiliation_string":"Nanjing Medical University , , ,","institution_ids":["https://openalex.org/I83519826"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5160137932","display_name":"Jing Li","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I83519826","display_name":"Nanjing Medical University","ror":"https://ror.org/059gcgy73","country_code":"CN","type":"education","lineage":["https://openalex.org/I83519826"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Jing Li","raw_affiliation_strings":["Jiangsu Institute of Nuclear Medicine , , ,","Nanjing Medical University , , ,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Jiangsu Institute of Nuclear Medicine , , ,","institution_ids":[]},{"raw_affiliation_string":"Nanjing Medical University , , ,","institution_ids":["https://openalex.org/I83519826"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5139420718","display_name":"Xinru Li","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I83519826","display_name":"Nanjing Medical University","ror":"https://ror.org/059gcgy73","country_code":"CN","type":"education","lineage":["https://openalex.org/I83519826"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Xinru Li","raw_affiliation_strings":["Jiangsu Institute of Nuclear Medicine , , ,","Nanjing Medical University , , ,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Jiangsu Institute of Nuclear Medicine , , ,","institution_ids":[]},{"raw_affiliation_string":"Nanjing Medical University , , ,","institution_ids":["https://openalex.org/I83519826"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021587318","display_name":"Ling Qiu","orcid":"https://orcid.org/0000-0002-9704-8435","observed_orcids":["https://orcid.org/0000-0002-9704-8435"]},"institutions":[{"id":"https://openalex.org/I83519826","display_name":"Nanjing Medical University","ror":"https://ror.org/059gcgy73","country_code":"CN","type":"education","lineage":["https://openalex.org/I83519826"]}],"countries":["CN"],"is_corresponding":true,"raw_author_name":"Ling Qiu","raw_affiliation_strings":["Jiangsu Institute of Nuclear Medicine , , ,","Nanjing Medical University , , ,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Jiangsu Institute of Nuclear Medicine , , ,","institution_ids":[]},{"raw_affiliation_string":"Nanjing Medical University , , ,","institution_ids":["https://openalex.org/I83519826"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5042147140","display_name":"Jianguo Lin","orcid":"https://orcid.org/0000-0003-1658-615X","observed_orcids":["https://orcid.org/0000-0003-1658-615X","https://orcid.org/0000-0003-1018-9794"]},"institutions":[{"id":"https://openalex.org/I83519826","display_name":"Nanjing Medical University","ror":"https://ror.org/059gcgy73","country_code":"CN","type":"education","lineage":["https://openalex.org/I83519826"]}],"countries":["CN"],"is_corresponding":true,"raw_author_name":"Jianguo Lin","raw_affiliation_strings":["Jiangsu Institute of Nuclear Medicine , , ,","Nanjing Medical University , , ,"],"raw_orcid":"https://orcid.org/0000-0003-1018-9794","affiliations":[{"raw_affiliation_string":"Jiangsu Institute of Nuclear Medicine , , ,","institution_ids":[]},{"raw_affiliation_string":"Nanjing Medical University , , ,","institution_ids":["https://openalex.org/I83519826"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5021587318","https://openalex.org/A5042147140"],"corresponding_institution_ids":["https://openalex.org/I83519826"],"apc_list":{"value":4500,"currency":"USD","value_usd":4500},"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.81889096,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11395","display_name":"Radiopharmaceutical Chemistry and Applications","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11395","display_name":"Radiopharmaceutical Chemistry and Applications","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10522","display_name":"Medical Imaging Techniques and Applications","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10754","display_name":"Neuroendocrine Tumor Research Advances","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/prostate-cancer","display_name":"prostate cancer","score":0.9380000233650208},{"id":"https://openalex.org/keywords/prostate-specific-membrane-antigen","display_name":"prostate-specific membrane antigen","score":0.8429999947547913},{"id":"https://openalex.org/keywords/neurotensin-receptor-1","display_name":"neurotensin receptor 1","score":0.9850000143051147},{"id":"https://openalex.org/keywords/dota-chelator","display_name":"DOTA chelator","score":0.6309999823570251},{"id":"https://openalex.org/keywords/positron-emission-tomography","display_name":"positron emission tomography","score":0.5270000100135803},{"id":"https://openalex.org/keywords/spect-ct","display_name":"SPECT/CT","score":0.9259999990463257},{"id":"https://openalex.org/keywords/theranostics","display_name":"theranostics","score":0.7080000042915344},{"id":"https://openalex.org/keywords/radiolabeled-peptides","display_name":"radiolabeled peptides","score":0.41600000858306885},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.6890000104904175},{"id":"https://openalex.org/keywords/cytotoxicity","display_name":"cytotoxicity","score":0.7459999918937683}],"concepts":[{"id":"https://openalex.org/C2779723316","wikidata":"https://www.wikidata.org/wiki/Q6459234","display_name":"LNCaP","level":4,"score":0.9298999905586243},{"id":"https://openalex.org/C2780192828","wikidata":"https://www.wikidata.org/wiki/Q181257","display_name":"Prostate cancer","level":3,"score":0.8737999796867371},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.7875000238418579},{"id":"https://openalex.org/C20417620","wikidata":"https://www.wikidata.org/wiki/Q4140229","display_name":"Glutamate carboxypeptidase II","level":4,"score":0.7099999785423279},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.6348999738693237},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.5044999718666077},{"id":"https://openalex.org/C2778976297","wikidata":"https://www.wikidata.org/wiki/Q419576","display_name":"Neurotensin","level":4,"score":0.47909998893737793},{"id":"https://openalex.org/C2781197716","wikidata":"https://www.wikidata.org/wiki/Q864574","display_name":"Biomarker","level":2,"score":0.46209999918937683},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.43880000710487366},{"id":"https://openalex.org/C2776235491","wikidata":"https://www.wikidata.org/wiki/Q9625","display_name":"Prostate","level":3,"score":0.375900000333786},{"id":"https://openalex.org/C2779931791","wikidata":"https://www.wikidata.org/wiki/Q161515","display_name":"DOTA","level":3,"score":0.3476000130176544},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.3009999990463257},{"id":"https://openalex.org/C2780962315","wikidata":"https://www.wikidata.org/wiki/Q1988832","display_name":"Bicalutamide","level":5,"score":0.2987000048160553},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.2930999994277954},{"id":"https://openalex.org/C2777307743","wikidata":"https://www.wikidata.org/wiki/Q24782815","display_name":"Neurotensin receptor","level":5,"score":0.29280000925064087},{"id":"https://openalex.org/C553184892","wikidata":"https://www.wikidata.org/wiki/Q1141429","display_name":"Flow cytometry","level":2,"score":0.28870001435279846},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.27649998664855957},{"id":"https://openalex.org/C2983331546","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer therapy","level":3,"score":0.2743000090122223},{"id":"https://openalex.org/C96232424","wikidata":"https://www.wikidata.org/wiki/Q4118072","display_name":"Cancer cell","level":3,"score":0.27239999175071716},{"id":"https://openalex.org/C2781406297","wikidata":"https://www.wikidata.org/wiki/Q409450","display_name":"Prostate-specific antigen","level":4,"score":0.26899999380111694},{"id":"https://openalex.org/C3020616263","wikidata":"https://www.wikidata.org/wiki/Q1216998","display_name":"Tumor cells","level":2,"score":0.25609999895095825},{"id":"https://openalex.org/C87874733","wikidata":"https://www.wikidata.org/wiki/Q18039844","display_name":"PCA3","level":4,"score":0.2549000084400177}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1021/acs.jmedchem.6c02236","doi":"https://doi.org/10.1021/acs.jmedchem.6c02236","is_oa":false,"landing_page_url":"https://doi.org/10.1021/acs.jmedchem.6c02236","pdf_url":null,"source":{"id":"https://openalex.org/S162030435","display_name":"Journal of Medicinal Chemistry","issn_l":"0022-2623","issn":["0022-2623","1520-4804"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","jufo-3","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320006","host_organization_name":"American Chemical Society","host_organization_lineage":["https://openalex.org/P4310320006"],"host_organization_lineage_names":["American Chemical Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Medicinal Chemistry","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9537000060081482}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320317802","display_name":"Jiangsu Commission of Health","ror":null},{"id":"https://openalex.org/F4320322769","display_name":"Natural Science Foundation of Jiangsu Province","ror":"https://ror.org/01h0zpd94"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":35,"referenced_works":["https://openalex.org/W2038578630","https://openalex.org/W2050761279","https://openalex.org/W2782452802","https://openalex.org/W2914917332","https://openalex.org/W2930943947","https://openalex.org/W2942771707","https://openalex.org/W2955556249","https://openalex.org/W3089754185","https://openalex.org/W3134860719","https://openalex.org/W3164137106","https://openalex.org/W3213895728","https://openalex.org/W4206729433","https://openalex.org/W4213241853","https://openalex.org/W4234670614","https://openalex.org/W4294946291","https://openalex.org/W4386253998","https://openalex.org/W4387434673","https://openalex.org/W4387904549","https://openalex.org/W4391323919","https://openalex.org/W4396724950","https://openalex.org/W4399653159","https://openalex.org/W4400414544","https://openalex.org/W4402953919","https://openalex.org/W4403775635","https://openalex.org/W4404432155","https://openalex.org/W4405284819","https://openalex.org/W4409520794","https://openalex.org/W4411241646","https://openalex.org/W4412162253","https://openalex.org/W4412677057","https://openalex.org/W4413054609","https://openalex.org/W4416089379","https://openalex.org/W4416536284","https://openalex.org/W4416695437","https://openalex.org/W7125635196"],"related_works":["https://openalex.org/W2520661961","https://openalex.org/W4224771907","https://openalex.org/W2175765437","https://openalex.org/W4406232280","https://openalex.org/W7129003956","https://openalex.org/W7148524344","https://openalex.org/W7165012360","https://openalex.org/W4399490365","https://openalex.org/W4318035590","https://openalex.org/W2094194375"],"abstract_inverted_index":{"Abstract":[0],"Prostate-specific":[1],"membrane":[2],"antigen":[3],"(PSMA)":[4],"is":[5,18],"a":[6,138],"key":[7],"biomarker":[8],"for":[9,53,59,79,118,132,141],"prostate":[10],"cancer":[11],"(PCa),":[12],"while":[13],"neurotensin":[14],"receptor":[15],"1":[16],"(NTSR1)":[17],"positive":[19],"in":[20,66,88,115],"PSMA-negative":[21],"PCa":[22,133],"lesions.":[23],"For":[24],"comprehensive":[25,142],"diagnosis":[26,134],"and":[27,43,46,56,69,91,135,143],"therapy":[28],"of":[29,147],"PCa,":[30],"we":[31],"synthesized":[32],"dual-targeted":[33,130],"PSNT-AB":[34],"(combining":[35],"PSMA-targeted":[36],"EuK,":[37],"NTSR1-targeted":[38],"NT-20.3,":[39],"albumin-binding":[40],"4-p-tolylbutyric":[41],"acid":[42],"DOTA":[44],"moieties)":[45],"prepared":[47],"[68Ga]Ga/[177Lu]Lu-PSNT-AB.":[48],"[68Ga]Ga-PSNT-AB":[49,86],"possessed":[50],"high":[51],"affinity":[52,58],"PSMA-positive":[54],"LNCaP":[55,116],"moderate":[57],"NTSR1-positive":[60],"PC-3":[61,92],"cells.":[62],"Probes":[63],"accumulated":[64],"time-dependently":[65],"relevant":[67],"cells,":[68],"[177Lu]Lu-PSNT-AB":[70,113],"exerted":[71],"potent":[72],"cytotoxicity.":[73],"Pharmacokinetics":[74],"revealed":[75,84],"prolonged":[76],"blood":[77],"half-lives":[78],"both":[80],"probes.":[81],"PET":[82],"imaging":[83],"persistent":[85],"uptake":[87],"LNCaP,":[89],"22Rv1":[90],"tumors":[93,117],"(10.29":[94],"\u00b1":[95,99,103],"0.25%":[96],"ID/g,":[97,101],"6.61":[98],"0.30%":[100],"3.74":[102],"0.12%":[104],"ID/g":[105],"at":[106,119],"3":[107],"h":[108],"post-injection).":[109],"SPECT/CT":[110],"showed":[111],"sustained":[112],"retention":[114],"least":[120],"24":[121],"h.":[122],"These":[123],"results":[124],"demonstrated":[125],"that":[126],"[68Ga]Ga/[177Lu]Lu-PSNT-AB":[127],"are":[128],"promising":[129],"probes":[131],"therapy,":[136],"offering":[137],"potential":[139],"strategy":[140],"effective":[144],"precision":[145],"management":[146],"PCa.":[148]},"counts_by_year":[],"updated_date":"2026-11-01T11:40:01.658920","created_date":"2026-10-30T00:00:00"}